{
    "Trade/Device Name(s)": [
        "Stratus CS Acute Care CardioPhase hsCRP TestPak",
        "Stratus CS Acute Care CardioPhase hsCRP Test Pak"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K062924",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060369"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQD"
    ],
    "Summary Letter Date": "September 27, 2006",
    "Summary Letter Received Date": "September 28, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5270"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "C-reactive protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Stratus CS Acute Care platform"
    ],
    "Method(s)/Technology(ies)": [
        "Radial Partition Immunoassay (RPIA)",
        "Two-site sandwich assay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay",
        "Test Pak"
    ],
    "Document Summary": "FDA 510(k) summary for Stratus CS Acute Care CardioPhase hsCRP TestPak for quantitative determination of CRP in plasma using RPIA technology",
    "Indications for Use Summary": "Quantitative determination of C-reactive protein in lithium and sodium heparin plasma for detection and evaluation of infection, tissue injury, inflammatory disorders, and as an independent risk marker for cardiovascular disease, for use by trained health care professionals in clinical laboratory and point of care settings",
    "fda_folder": "Immunology"
}